Peptide hormone sensors using human hormone receptor-carrying nanovesicles and graphene FETs

被引:0
作者
Sae Ryun Ahn
Ji Hyun An
Seung Hwan Lee
Hyun Seok Song
Jyongsik Jang
Tai Hyun Park
机构
[1] Seoul National University,School of Chemical and Biological Engineering
[2] Semiconductor R&D Center,Department of Bionano Engineering
[3] Samsung Electronics,Sensor System Research Center
[4] Hanyang University,undefined
[5] Korea Institute of Science and Technology,undefined
来源
Scientific Reports | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Hormones within very low levels regulate and control the activity of specific cells and organs of the human body. Hormone imbalance can cause many diseases. Therefore, hormone detection tools have been developed, particularly over the last decade. Peptide hormones have a short half-life, so it is important to detect them within a short time. In this study, we report two types of peptide hormone sensors using human hormone receptor-carrying nanovesicles and graphene field-effect transistors (FETs). Parathyroid hormone (PTH) and glucagon (GCG) are peptide hormones present in human blood that act as ligands to G protein-coupled receptors (GPCRs). In this paper, the parathyroid hormone receptor (PTHR) and the glucagon receptor (GCGR) were expressed in human embryonic kidney-293 (HEK-293) cells, and were constructed as nanovesicles carrying the respective receptors. They were then immobilized onto graphene-based FETs. The two hormone sensors developed were able to detect each target hormone with high sensitivity (ca. 100 fM of PTH and 1 pM of GCG). Also, the sensors accurately recognized target hormones among different types of peptide hormones. In the development of hormone detection tools, this approach, using human hormone receptor-carrying nanovesicles and graphene FETs, offers the possibility of detecting very low concentrations of hormones in real-time.
引用
收藏
相关论文
共 100 条
[1]  
Lübke K(1976)Hormone receptors Angew. Chem. Int. Ed. 15 741-748
[2]  
Schillinger E(1972)The mode of action of hormones Angew. Chem. Int. Ed. 11 7-16
[3]  
Töpert M(2005)Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use Endocr. Rev 26 688-703
[4]  
Schauer R(2009)Plasma parathyroid hormone and the risk of cardiovascular mortality in the community Circulation 119 2765-2771
[5]  
Hodsman AB(1999)Receptors for PTH and PTHrP: their biological importance and functional properties Am. J. Physiol. Renal Physiol. 277 F665-F675
[6]  
Hagström E(2011)PTHrP stimulates prostate cancer cell growth and upregulates aldo–keto reductase 1C3 Cancer Lett. 306 52-59
[7]  
Mannstadt M(2000)High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases Histopathology 37 536-545
[8]  
Juppner H(2016)A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies Am. J. Clin. Pathol. 75 734-738
[9]  
Gardella TJ(2000)Detection of gonadotropin-releasing hormone receptor in normal human pituitary cells and pituitary adenomas using immunohistochemistry Virchows Archiv 437 264-269
[10]  
Downs TM(2002)Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy Clin. Chem. 48 1731-1738